U.S. Markets open in 39 hrs, 52 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 5.05 09:43 AM EDT | |
|---|---|---|
| Day High | 5.28 09:32 AM EDT |
|
| Range | 0.23 |
| Volume | 120,662 | |
|---|---|---|
| 30-Day Avg Vol | 205,000 |
|
| Difference | -41.14% |
| Market Cap | 158.52 M | |
|---|---|---|
| Mkt Cap Chg | -6.82 M |
| Shares Out | 31.02 M | |
|---|---|---|
| % Shrs Traded | 0.39% | |
| 1yr EPS Est | -1.568 |
| 52-Wk Low | 4.50 6/22/09 | |
|---|---|---|
| 52-Wk High | 17.50 7/21/08 |
|
| Range | 13.00 |
| Prev Close | 5.33 7/1/09 | |
|---|---|---|
| Today's Open | 5.24 | |
| Change | -1.69% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.71 M |
| Revenue (LFY) | 67.67 M | |
|---|---|---|
| Earnings (LFY) | -44.67 M | |
| Earnings (MRQ) | -1.79 M | |
| Next Earn Est | -0.512 | |
| Next Earnings | 08/03/2009 |
|
| EPS (TTM) | -1.04 | |
| 1yr EPS Growth | -50.77% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -3.00 | |
| PEG Ratio | — | |
| Return on Equity | -32.79 | |
| Beta | 1.56 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Progenics Pharmaceuticals is taking a proactive approach to fighting serious diseases such as HIV and cancer. The biotech company won its first FDA approval in 2008 with Relistor (methylnatrexone), which ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.512 8/3/09 | — — |
—
—
|
| Last Quarter | -0.285 3/31/09 | -0.06 3/31/09 |
0.225
Beat
|
| 2 Quarters Ago | -0.208 12/31/08 | -0.49 12/31/08 |
-0.282
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 20.90 M | 67.67 M |
| Gross Profit | -6.38 M | 63.06 M |
| Operating Income | -2.58 M | -50.91 M |
| Net Income | -1.79 M | -44.67 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts